ARCHIVES

Changes In Clinical Trials Mechanism Inevitable, But NCI Says It will Heed Critics Of Proposals

This article is from The Cancer Letter archive.

Vol. 12 No. 16 | April 18, 1986

Download PDF Visit The Full Archive

Related Articles

NCAB Disproves W. Virginia Construction Grant, Okays Funding Three New, Three Carryover Awards

May 24, 1985

“Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says

September 25, 1998

First Mobil NMR Scanner Goes Into Operation At Temple

June 22, 1984

Big Get Bigger, Litton Primate Contract Renewed

September 19, 1975

Congress Asked To Equalize Cuts, Add $20 million For Centers

April 25, 1980

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005